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Electroporation serves as a promising non-viral gene delivery approach, while its 
current configurations carry drawbacks associated with high-voltage electrical pulses and 
heterogeneous treatment on individual cells. Here, we developed a new micropillar array 
electroporation (MAE) platform to advance the delivery o f plasmid DNA and RNA to 
mammalian cells. By introducing well-patterned micropillar array on the electrode 
surface, the number o f pillars each cell faces varies with its cell membrane surface area, 
despite their large population and random locations. In this way, cell size specific 
electroporation is conveniently done and contributed to a 2.5-3 fold increase on plasmid 
DNA transfection and an additional 10-55% knockdown with targeting siRNA, 
respectively. The delivery efficiency varies with the number and size o f the micropillars 
as well as their pattern density. As MAE works like many single cell electroporation is 
carried out in a parallel fashion, the electrophysiology response of individual cells is 
representative, which has the potential to gear up the tedious, cell-specific protocol 
screening process in the current in vitro bulk electroporation (i.e., electroporation to a 
large population of cells). Its success might facilitate the wide adoption of electroporation 
as a safe and effective non-viral gene delivery approach needed in many biological 
research and clinical treatments.
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Cancer has a serious impact in the United States. According to the Centers for 
Disease Control and Prevention (CDC), cancer is the second cause o f death in the United 
States in adults (NVSR 2014). The American Cancer Society (ACS) gives out specific 
data that shows there were 1,665,540 cancer cases diagnosed and 585,720 cancer deaths 
in 2014 (ACS 2014). The ACS also indicates if this situation lasts during an American’s 
lifetime, one in two men and one in three women will develop cancer. As shown in 
Figure 1-1, the top cancers that killed the most people in the United States in males are: 
lung and bronchus (87,260 deaths), prostate (29,720 deaths), colon and rectum (26,300 
deaths), pancreas (19,480 deaths), and liver and intrahepatic bile duct (14,890 deaths), 
and in females they are: lung and bronchus (72,220 deaths), breast (39,620 deaths), colon 
and rectum (24,530 deaths), pancreas (18,980 deaths), and ovary (14,030 deaths) (ACS 
2014).
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Figure 1-1: Estimated cancer deaths in the US in 2014 (American Cancer Society)
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To prevent deterioration, many types o f cancer treatment were developed. To 
date, the primary cancer treatment methods include surgery following chemotherapy 
and/or radiation therapy. However, this traditional treatment will cost greatly both 
economically and psychosomatically. Thus, some other options were researched and 
developed. Some mature and already applied methods immunotherapy, targeted therapy 
and hormone therapy. Individual treatment will be suggested according to the diagnosis. 
However in most cases, a multiple combined treatments will be applied (NCI 2014).
As a cancer treatment method, immunotherapy shows great potential. 
Immunotherapy is defined as the treatment that fights diseases with certain parts o f a 
patient’s own immune system. The immune system is a functional system with the 
composition of organs, special cells, and substances. It protects people from infections 
and some other diseases. The popular immunotherapy on cancer treatment include: 
monoclonal antibodies, immune checkpoint inhibitors, genetic vaccines, and other non­
specific immunotherapies (ACS 2014).
A vaccine is a biological agent to fight against a particular disease, making it 
possible to obtain active acquired immunity. The typical vaccines are usually pathogenic 
microorganisms. They are the results o f weakened or dead form (Fiore et al, 2009). When 
the biological agent is injected into human bodies, the immune system begins to work 
and identify such formulations as a threat. To protect from infection, antigens would be 
produced to destroy the microorganisms. Such behavior will be recorded. So the immune 
system can more easily identify and destroy it in the later encounters (CDC 2011).
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In the history o f the development o f vaccines, genetic vaccines are considered one 
o f the most important discoveries. From the early 1990’s, an immune response in the 
plasmidencoded antigen by the introduction o f plasmid DNA led to the rapid 
development o f genetic vaccines (Alarcon, 1999). Generally, the DNA vaccine is 
produced through delivering the plasmid with genetic information into the target cells. 
While information encoded on plasmids was expressed, the transfected cells obtained the 
antigen, resulting in an immune response. Compared to traditional vaccine (recombinant 
bacteria or viruses), the genetic vaccine contains only the genetic information, produced 
under the water environment o f living cells and unwanted activities that do not occur 
besides antibody responses (Robinson, 2000).
The distinct advantages o f a genetic vaccine are relatively low in cost and the 
simplicity o f manufacturing and use. In the past 20 years, through the efforts o f scientists, 
the study o f genetic vaccine has developed from laboratory to human clinical trials. To 
date, genetic vaccine has been conducted for cancer (Robinson, 2000), HIV-infection 
(Douek, 2009), or malaria (Nadjm & Behrens, 2012).
Plasmid DNA and mRNA are the main research areas in genetic vaccine. A 
typical case o f DNA vaccine manufacture is gene gun delivery. Inert particles are usually 
used for precipitate plasmid. Through external factors, like a helium blast, genetic DNA 
is transferred into the cell (Fisher et al., 2007). An mRNA is an immunogenic and 
programmable molecule, which is preferred as an antigen encoding gene for cell-based 
immunotherapy. In contrast to the DNA vaccine, the expression o f mRNA vaccine is 
more efficient because it does not need to cross the nuclear envelope. This advantage 
aroused the interest o f scientists and developed a series o f methods to stimulate immune
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responses through the use o f mRNA. However, the shortages are always accompanied by 
conveniences. A major disadvantage o f using the mRNA vaccine is the time expense on 
the processes o f harvesting, culturing, and loading. The efficacy o f genetic vaccines in 
some immunotherapy systems is still considered not satisfactory enough. To improve 
gene delivery, efficiency becomes an urgent problem.
To achieve gene delivery from the external environment to the interior biological 
tissues or cells is an important procedure in immunotherapy. Along with the genetic 
technology growth, vested and foreseeable benefits had driven scientists to develop 
multiple approaches to implement gene delivery. Viral methods were used to transfer 
genes into the target cells. The viruses have very high gene transfer efficiency. Non-viral 
gene methods were also researched and used to overcome the negative effects caused by 
viral vectors. Chemical methods and physical methods are the two main research 
directions (Kamimura et al., 2011).
Due to the unique advantages, electroporation was researched and applied 
frequently as a physical Non-viral gene delivery method. When working in a sterile 
environment, the risk o f infection is considered is redundant in electroporation. The 
undemanding requirement on device and operation gained a wide application in all gene 
research area. Although electroporation experienced low performance at the very 
beginning of its development, the transfection efficiency and cell viability improved a lot 
during decade’s o f research and showed great potential (Neumann et al., 1982; Sugar & 
Neumann, 1984).
Scientists are paying more attention to electroporation. However, challenges are 
also significant and arduous. In the current bulk electroporation protocols, the actual
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pulse strength adopted in most bulk electroporation protocols fall in 0.5-1.0 KV/cm for 
mammalian cells and varies with cell type, source, and population. Such high-voltage 
pulses, though effective in improving the cell membrane’s permeability and probe 
uptake, inevitably lead to severe problems such as slow membrane recovery, harmful 
electrochemical reactions (e.g., water hydrolysis, leading to pH changes and bubble burst 
damage), and Joule heating (temperature variations), all detrimental to the cell’s survival 
fate.
To tackle the high-voltage issues, new systems with micro-/nanoscale features 
have recently been introduced by several research groups through closely patterning 
electrode pairs and/or sophisticated focusing the applied electric pulses. The rationale 
behind these micro-electroporation systems comes from when the two electrodes are 
brought close together and a low voltage is sufficient to generate pulses with a high 
enough field strength required for cell electroporation. However, most o f these 
micro/nanoscale systems still ignore the local electrical variations on individual cells 
among a large population, leaving many uncontrollable factors similar to what is in the 
bulk electroporation systems.
In order to solve this problem and accomplish size specific electroporation, we 
propose a new electroporation system named the Micro-pillar Array Electroporation 
(MAE) approach. In MAE, cells will be sandwiched between a plain plate electrode and a 
plate electrode composed of thousands o f micro-pillars in a well-patterned array format. 
This way, the number o f micro-pillars each cell faces varies with its membrane surface 
area, or the size o f the cells. This MAE setup is expected to leverage the current 
electroporation-based delivery approach in terms of efficiency and cell viability. To test
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our hypothesis with mammalian cell transfection, NIH 3T3 cells (use as model anchor 
cells) and K562 cells (use as model suspension cells) were used here. Cell viability and 
transfection efficiency were the focused areas o f the electroporation evaluation of 
reporter genes (pMaxGFP and pWizLuciferase) and their corresponding SiRNAs to 




Gene delivery methods can be divided into two types: viral and non-viral 
methods, or vectors which are summarized in Figure 2-1. From the scheme we can figure 
out the viral methods which include the use o f viruses such as adenovirus, retrovirus, and 
vacciniavirus. The non-viral methods are also researched in two areas: chemical methods, 
including lipoplex and polyplex, and physical methods, including microinjection, gene 
gun, and electroporation.
Gene Delivery m ethods
Viral m ethods Non-viral m ethods
Adenovirus Chemical m ethods Physical m ethods
Retrovirus lipoplex microinjection
Vacciniavirus polyplex gene gun
electroporation
Figure 2-1: Gene delivery methods
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Gene therapy generally requires a specific delivery o f genes into the chromosome 
of a target cell. Treatment success rate is up to whether the agent or vector might be used 
for delivering therapeutic genes. Vector is a carrier o f useful therapeutic gene. Vector has 
multiple functions, including avoidance degradation, promoting the gene into the target 
cells, and to ensure that the gene transcription is in the nucleus (Walther & Stein, 2000). 
In an ideal case, the gene delivery vectors should be efficient and safe. Safe transfer is 
described as a no-risk o f introducing an infection or vector immune response is minimal 
(Walther & Stein, 2000; Peng, 1999).
A recent study suggests that some carriers have been well researched and 
developed. A common carrier has not been found to be used universally. So, how to 
choose a carrier that people need to consider many factors, such as the entire course o f 
treatment, if  a short-term or chronic treatment is better. As o f spring 2014, there have 
been about 40 variants o f the vectors have been evaluated or applied to gene therapy 
clinical trials (Wiley, 2013). These carriers are usually divided into two main categories: 
viral or non-viral methods.
2.1.1 Viral Vectors Gene Delivery
Viruses can be used to transfer genes into the target cells. Typically, working as 
the infection agent, the viruses have very high gene transfer efficiency. On the other 
hand, for the host organisms, viruses have very good adaptability. These advantages often 
make the viruses considered in gene therapy to transfer therapeutic genes into the 
targeted cells.
Although viruses differ in structures, almost all viruses have some universal 
feature. Such as, all viruses have a structure called capsid. Its role is used to save proteins
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and glycoproteins o f genetic material. There is a very interesting phenomenon: genetic 
material viruses carried is also varied, including the DNA, RNA, or even certain enzymes 
are also different. Therefore, it is necessary to identify the virus based on the 
characteristics o f the composition of the virus genes. Furthermore, there are some 
particular viruses in their capsid surrounding a membrane structure. It can penetrate the 
host's cell membranes through membrane fusion (Campbell & Robinson, 1998; Coffin, 
2014).
The working principle o f the viral vector is to utilize the ability o f the viruses that 
can enter the cells and the genetic material can be delivered into the nucleus. In general, 
after the operation by the researchers, the majority o f the original viruses’ genes are 
replaced by the therapeutic genes. Thus, the viruses injected into the vector do not cause 
the disease. Common viral vectors include: retrovirus, lentivirus, and adenovirus. 
Different viruses vectors vary in gene delivery efficiency. As a result, depending on the 
required characteristics o f each case and the associated clinical studies, researchers can 
select a specific viral vector (Ginn et al., 2013; Campbell & Robinson, 1998; Coffin, 
2014; Nisole & Saib, 2014; Coffin, 1997; Cooray et al., 2012; Sakuma et al., 2012).
In earlier studies, the viral vector has been widely developed. However, in the 
actual treatment, there are usually more than one type o f cells infected with the virus. 
Therefore, not only the targeted cells, but the healthy cells also present the risk o f being 
infected. During therapy, once the vaccine or treatment fails, the validity o f the use of 
viral vectors again proved to be difficult. On the other hand, the same viral vector is 
typically not used in various vaccines or gene therapies. Introducing a variety o f viral 
vectors would increase the risk o f infection. In addition, sometimes the patient's immune
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system might cause gene therapy to fail eventually (Nayak & Herzog, 2009; Zhou et al., 
2004).
If the introduction of the virus is not accepted, there is another consideration. The 
smooth insertion o f genetic material and transduction, effectively splitting the target cells 
to become one o f the essential conditions o f viral vectors. However, there are some cells 
that are highly resistant to retroviral infection and transduction in humans. On the other 
hand, in the copy process, transcriptional gene may be an over-expression, to produce 
beyond the desired amount o f protein. Also, this situation will lead to harmful effects, 
such as inflammation or allergies. In addition, integrase enzyme is able to insert genetic 
material in the target cell genome at any point. This posed some problems. If the genetic 
material is inserted into the wrong position o f the genome, gene mutation may occur, 
which has been demonstrated in clinical trials (Thrasher et al., 2006; Umov et al., 2005).
2.1.2 Non-Viral Delivery Methods
In order to overcome the negative effects caused by viral vectors, non-viral gene 
vectors have been frequently used. Common forms o f non-viral vectors for gene therapy 
are: plasmid DNA encoding o f a transgene, transgenic, local or systemic such as injection 
into the blood vessel. In these processes, the expression yield o f the desired therapeutic 
protein would treat the disease. Peripheral arterial occlusive disease (Comerota et a l,  
2002), arthritis (Bloquel et al., 2004) and cancer (Daugimont et al., 2001) are the most 
popular non-viral gene therapy clinical application.
Non-viral delivery techniques offer cost-effective and less toxic alternatives to 
viral methods. Non-viral methods for transfection can be categorized into two groups, 
chemical and physical methods. Chemical methods o f transfection include lipoplex and
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polyplex. Unlike the viral transfection, chemical transfection is not limited by the size o f 
the genetic payload. Physical methods involve creation o f transient pores in the cell 
membrane using physical forces. The major current physical methods are microinjection, 
gene gun, and electroporation.
Using a plasmid vector is one o f the many methods to insert therapeutic genes. 
Most commonly it occurs in bacteria and unicellular microorganism’s plasmid, a small 
circular double stranded DNA molecule. In the biological world, organism keeps 
functioning by a plasmid gene delivery, such as antibiotics. In the world o f bacteria, the 
plasmid can often be delivered by a non-breeding gene transfer. It happens frequently 
while genetic materials exchange between bacteria. For example, a plasmid containing 
genes to obtain the antibiotic resistance, by gene transfer, the gene can be used on the 
bacteria.
Natural and artificial plasmids now had been regarded as a basic tool o f genetics 
and biotechnology. Plasmids normally used in the laboratory for small DNA and gene 
replication. Sometimes it also works as a method in the production of large-scale proteins. 
This technology is very mature; many plasmids have been fully commercialized.
Plasmid DNA may be used alone and expressed therapeutic gene. This feature 
was first discovered in an intramuscular injection. The plasmid DNA was used as a 
marker for validation and gene expression measurement (Wolff et al., 1990). Reporter 
gene (marker gene) is a very effective method of marking. In recent clinical applications, 
this labeling method has been widely used in vascular disease. The principle is the 
expression of a therapeutic gene, which encodes for antigenic growth, basic fibroblast 
growth, or hepatocyte growth (Nikol et al., 2008; Powell et al., 2008).
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Another active area of the plasmid DNA therapy lies in the development of 
genetic vaccines. There have been several already achieved approaches o f plasmid DNA 
genetic vaccines in influenza, HIV and hepatitis C (Seaman et al., 2005; Gudmundsdotter 
et al., 2006; Sandstrom et al., 2008). Using these genetic vaccines may reduce or limit 
gene transcription (Li & Huang, 2000). When the plasmid vector DNA goes into the 
nucleus o f a target cell, the efficiency of DNA must be transcribed because o f transgene 
expression and cell division is achieved. Introduction of therapeutic DNA into target cells 
will hold this function.
When an unrecognized substance enters the patient's body, his immune system 
would be activated. Affected immune system can be reduced by therapeutic efficacy.
This effect is significant during recurring treatment. Therefore, before introducing o f the 
vector, the protein purification process is necessary. In the commercial system, this step 
is usually achieved by separating the DNA vector. Therefore, the yield and purity o f the 
antigen will cause problems. In treatment, it is often taking risks caused by antibody 
response. Furthermore, the size o f the inserted DNA also has a requirement. It is usually 
30-40 kb o f base pairs (Del et al., 1998; Vivian et al., 2001; Pinto et al., 2012).
21.3 Chemical Transfection Methods
Figure 2-2 shows the general chemical methods for gene delivery. Typically, 





Figure 2-2: The schematic o f the working principles o f chemical transfection method.
2.1.3.1 Lipoplex. Lipoplex is a complex o f cationic lipids with DNA. Lipoplex 
mediated DNA delivery was first introduced by Feigner in 1980 (Feigner et al., 1987) 
and extensively explored thereafter for both in vivo and in vitro therapeutic probe 
delivery. Lipoplexes were synthesized through the electrostatic interactions between 
positively charged lipids and negatively charged DNA (Ma et al., 2007). Early studies 
believed that DNA molecules enter cells when lipoplex is directly fused with cell plasma 
membrane. However, the recent studies showed that the DNA delivery by lipoplex 
mainly proceeded through endocytosis (Feigner et al., 1987).
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The transfection efficiency o f lipoplex is low when compared to the viral vectors. 
Because o f its advantages over viral vectors in terms of health risks, they still attract 
much attention for both in vivo and in vitro delivery investigations. Great efforts have 
been made to improve its delivery effectiveness (Zuhom et al., 2002; Jordan & Wurm, 
2004; Davis, 2002).
2.1.3.2 Polyplex. The polyplex is a complex o f cationic polymers with DNA 
(Yang & May, 2008). Like lipoplex, polyplex is regulated by ionic interactions between 
cationic polymers and DNA (How et al., 2004). One big difference between polyplex and 
lipoplex lies on their different DNA release processes inside the cell cytoplasm. Polyplex 
made of DNA and polyethylenimine, chitosan, or trimethylchitosan have their own ways 
for endosome disruption (How et al., 2004) compared to other vectors.
The use o f polyplex has several advantages, such as low immune response, 
convenience for cell or tissue targeting, and no restriction on the size o f the DNA to be 
transported. Moreover, it is very easy to produce polyplex with a large quantity (Ulasov 
et al., 2011). In the past decades, the polyplex research has achieved very promising 
progress in both in vivo and in vitro gene delivery. Among the polyplexes, the polyethy­
lenimine based polyplex was found to be one o f the most efficient ones (Ulasov et al.,
2011). Their high density o f amino groups results in efficient condensation o f DNA and 
reasonable transfection in eukaryotic cells at physiological pH value (Vancha et al.,
2004).
2.1.4 Physical Transfection Methods
2.1.4.1 Biolistics (gene gun). Biolistics, also known as a gene gun, has been 
widely used for gene delivery. A Helios gun with a modified barrel is used to deliver
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carrier particles over a wide area during biolistic transfection (O'Brien & Lummis, 2011). 
Obviously, the barrel could cause severe damage to cells or tissues (Uchida et al., 2009). 
The most commonly used carrier particle size is ~1 pm. The biolistic damage can be 
reduced by choosing smaller particles to carry DNA (Cui & Mumper, 2003). It has been 
reported that particles o f 100-180 nm in size had shown successful transfection (O'Brien 
& Lummis, 2011). Even though the gene gun can successfully deliver naked DNA inside 
cells, its efficiency is quite low when compared to other delivery methods. In addition, 
DNA molecules inside the cells are often hindered by nuclease enzyme and further 
degraded before successful transfection (Mintzer & Simanek, 2009).
2.1.4.2 Microiniection. Microinjection is the process which uses micropipettes for 
DNA delivery to cells (Ansorge & Pepperkok, 1988). Microinjection can deliver DNA 
directly to the cell cytoplasm or the nuclei. However, the process was very time 
consuming and labor intensive. With the assistance o f computer controlled systems, 
microinjection could be done faster (Ansorge & Pepperkok, 1988), although still slow as 
compared to other approaches.
2.1.4.3 Electroporation. In 1982, Neumann and Zimmermann proposed an 
electrically mediated gene delivery system, i.e. electroporation. Nowadays, it has become 
one of the most powerful and effective techniques for the introduction of DNA into the 
cells (Kim et al., 2008). Figure 2-3 shows an overview o f electroporation. In 
electroporation, an electric pulse is applied, resulting in the formation o f pores on the cell 
membrane which facilitates the delivery o f genes into the cells (Kim et al., 2008). Both 
electroporation conditions and the cell properties have a significant effect on the delivery
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efficiency (Olofsson et al., 2007). Depending on the electroporation conditions, the pores 
can be transient, short-lived or long lived (Agarwal et al., 2009).
Anode DNA Cathode
uclem
Figure 2-3: Schematic o f the working principles o f electroporation.
Two areas o f electroporation studies are focused on gene delivery: bulk 
electroporation and single cell electroporation (Agarwal et al., 2009). A uniform electric 
field is involved in bulk electroporation (BE). A large number o f cells will be 
permeabilized at the same time (Teissie et al., 2005). On the other hand, only one single 
cell is involved in single cell electroporation (SCE) at a time. Usually, it happens in a 
micro-scaled device (Teissie et al., 2005).
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2.2 Electroporation
Electroporation is a biophysical phenomenon by applying an electrical field to the 
cells or tissues in order to increase cell membrane permeability so that it will achieve the 
chemicals, drugs, DNA, and other macromolecules introduced into the interior o f the 
cells (Neumann et al., 1982). Typically, the cells and plasmids would be mixed together, 
after the electroporation, and the plasmids can be within the cells. After this process, the 
cells will be cultured in the medium. Breed until they split again, creating new cells 
containing the plasmids information replication (Neumann et al., 1982; Sugar & 
Neumann, 1984). Electroporation is a very efficient method for introducing foreign genes 
into the tissue cells, especially mammalian cells.
2.2.1 Theory
Dr. Weaver had given a standard operation protocol o f electroporation in 2000.
1. Cells or tissues would be exposed in a high intensity electrical field. The 
duration was from nanosecond to millisecond.
2. The cell membrane would be charged.
3. The molecular structures within the cell membrane would localize
reorganized.
4. Transient pores would format.
5. Gene delivery and mass exchange would achieve through the transient
pores.
6. Cell membrane recovery (Weaver, 2000).
Cell membrane has a semi-permeable Bilayer structure. Molecules o f water and 
small soluble molecular can be freely transmitted, while macromolecules such as nucleic
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acids will not be allowed to pass through. Membranes can be viewed as separate and 
outside the boundaries o f the cell conductive electrolyte. When an external electric field 
was applied, the cell membrane would perform as a capacitor being charged. Equation 1 
describes the transmembrane potential AVm(t) induced across the cell membrane when 
an externally electric field Eext is applied:
AVm(t) = ~ f  Eext r  C0S(p [ 1 -  e ?] , Equation 1
where f  represents the form factor of the cell.
r represents the radius o f the cell.
(p is the angle between the membrane site and the direction o f the applied field.
t is the time after the electric pulse onset.
i  is the membrane charging time constant (Bernhardt & Pauly, 1973; J. M.
Escofffe et al., 2009; Neumann, 1992).
Equation 2 describes the impact o f the cell on the electric field distribution on the 
form factor f. The external solution a0, cell interior ai, the cell membrane am and 
thickness of the membrane d defined the form factor. For a spherical cell, when am «  o 
0 and ai (Neumann, 1992):
ffm( 2+•“*•)
/  = [1 + 2 ati °  r 1- Equation 2
r
Sometimes due to the applied electric field at that site and resting membrane 
potential AVres, the transmembrane potential can be the sum o f the induced potential and 
presented as Equation 3 (Mehrle et al., 1992):
AFC = /  Ec r  cos (p | l  -  e ~ j  + kVres, Equation 3
where AVc is the transmembrane potential o f the cell exceeding a certain threshold.
19
According to the research data, usually the value of AVc is in the range of 0.2 -
0.3 V (Gabriel & Teissie, 1997; Teissie & Rols, 1993). AVc is important, for it works as a 
dielectric breakdown o f the membrane. It means it is the power for forming aqueous 
pores (Hibino et al., 1991; Weaver, 2003; Zimmermann et al., 1974). Therefore, from 
Equation 3, another critical electric field is necessary for electroporation which is 
Equation 4:
n  AVc-  AVr es r n  .gc -  ------------------------------------------------------ Equation 4
f r  cos<p[l-e~r]
Equation 4 tells us if  an electric field Ec is applied, electroporation would process for cp, 
which is close to 0 and n. This means the aqueous pores will show up on the membrane 
facing the electrodes.
2.2.2 Physical Mechanism 
Under normal circumstances, macromolecules such as DNA would not go 
through the hydrophobic bilayer membrane by diffusion. Electroporation techniques can 
highly charge macromolecules and take them from one side to the other side o f the 
membrane. For the mechanism concerning an aqueous environment, it is an operation of 
opening the nanoscale holes on the bilayer structure. For phenomenon, electroporation 
and dielectric breakdown are very similar. By studying the mechanism’s action, they are 
completely different. The dielectric breakdown would ionize the target material, thereby 
forming an electrically conductive path. In this process, the nature o f the material 
produced a chemical change. However, electroporation is just the opposite. The chemical 
changes do not occur, and it is purely a physical displacement by pore formation on the 
lipid molecules as shown in Figure 2-4.
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Figure 2-4: Cell membrane lipids arrangement in hydrophobic (top) and hydrophilic 
(bottom) pore.
(https://en.wikipedia.0rg/wiki/Electr0p0rati0n#/media/File:P0re_schematic.svg)
As described previously, while an electrical pulse is applied, typical parameters 
would be 300-400 mV across the membrane (Weaver et al., 1996). Upon the existence of 
potential differences, the performance o f the cell membrane is more like a capacitor.
With the accumulation o f a charge, when the electric field strength reaches a critical 
value, the cell membrane will rearrange. Then a hydrophilic interface will be created by 
the bending o f lipid heads. Lastly, these conductive pores are going to face polar fates: 
reseal and heal or expand and rupture. The key factor to determine their fate is the critical 
defect size (Joshi & Schoenbach, 2000). To tell if  the pores exceed the limitation of 
critical defect size, the applied electric field, local mechanical stress, and bilayer edge 
energy are considered effective.
2.2.3 Effect Factors in Electroporation 
Physical mechanism explains the working principle. However, under real lab or 
clinical conditions, besides the electric properties, there are still several factors which
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might bring affections when performing an electroporation. These factors are listed as 
follows:
1. Cell size. According to Equation 1, when plasmids permeabilization is 
achieved, a larger size cell requires a relatively larger transmembrane potential. Thus, it is 
necessary to provide a different treatment for various sizes of the cells. In the actual case, 
when the cell size distribution is very wide (eg, Ehrlich ascites cells) if  specific treatment 
is not provided, it is difficult to get good results. Furthermore, it is conceivable that when 
electroporation is applied on non-spherical shaped cells, the cells orientation is also very 
important.
2. Temperature. It has been proven that it is good for the cell closure process 
to operate at a relative lower temperature. Also, after plasmids transfection, cell 
membrane resealing is in direct proportion to the temperature (Kinosita & Tsong, 1977b). 
More specifically, in gene delivery, lower temperature while transient pores format and 
higher temperature in an incubator for cell recovery had a good effect on transfection 
efficiency and cell viability (Rols et al. 1994).
3. Post pulse operation. Since the cells would be exposed in the electric field 
and the membrane would be recognized, cells suffer and are vulnerable at the moment 
when the transient pores form. Scientists have suggested that 15 min is a good period o f 
time for cell resealing after the electroporation (Gehl et al., 1998). Also, after the cells 
pipet into the culturing petri dishes to avoid any manipulation is good for cell viability 
(Zerbib et al., 1985).
4. Electrodes material. Electroporation process requires a short duration 
pulse. Good conductive metal are considered as electrodes material. Aluminum is the
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most popular choice. Usually, there would not be a problem for the short pulse. However, 
along with the requirement o f growth, the release o f the metal is a concern in a long 
duration pulse or a multiple pulses electroporation (Rols et al., 1994). Both the vibration 
of the PH value and the release o f metal ion would decrease the cells’ viability and 
transfection efficiency. Inert materials are highly recommended if  working as an 
electrode.
5. Medium. Since the plasmids, genes or any particles are in the environment 
of complicated chemicals during the electroporation, it is wise to be careful with the 
medium composition. Some researchers preferred the low conductivity media. Also, the 
careful usage o f calcium is necessary to avoid a sudden high intracellular level o f the 
electrolyte (Rols et al., 1994). However, the research on the affection o f medium 
composition is still under development. The opinions are not identical. Some authors 
advocate a right amount of calcium or magnesium in the buffer would increase cell 
viability and transfection efficiency (Neumann et al., 1996).
Additionally, heating during the electroporation has been proven to be not a 
problem, which is always a concern. In standard electroporation conditions (BTX 
cuvette), the temperature change caused by generated heating is less than 1°C (Bhatt et al., 
1990).
2.2.4 In Vivo Electroporation
In vivo electroporation has been introduced and has many applications in gene 
therapy. A pair o f plates or needles usually works as electrodes. Organs have been carried 
out for in vivo drug and gene delivery through electroporation. Two important features 
are discussed most frequently on in vivo electroporation.
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2.2.4.1 Electric field distribution. When performing an in vitro electroporation, it 
is obvious that needles electrodes would be more convenient during operation. Compared 
with the electric field o f the plate electrodes, the distribution o f the electric field o f the 
needles electrodes play a critical role. Since there is not a uniform distribution o f the 
electric field and usually the field strength is in the scale o f kilovolts per cm, it is much 
dangerous to operate in vivo electroporation on the body.
2.2.4.2 Vascular effects. In vivo electroporation, area covered by the scope of the 
electric pulse will produce a phenomenon called hypoperfusion. This is mainly due to 
two reasons. One is because o f the reflex contraction o f vascular resistance in the range 
of an electric field. The other is the inter impact o f interstitial edema and intravascular 
lactone structure due to the pressure drop caused by the projection effect (Gehl et al., 
2002). Reflex contraction o f the artery will continue about 1-2 minutes. During this 
period, interstitial edema will disappear because o f the reorganization o f the cell 
membrane. It is worth mentioning that the vascular effect o f cancer treatment seems 
particularly prominent, and is considered advantageous in cancer treatment (Sersa et al., 
1999; Gehl & Geertsen, 2000; Cemazar et al., 2001).
2.2.5 In Vitro Electroporation
In vitro gene delivery involves performing the experiments in a controlled 
environment outside a living organism. This type o f research aims at describing 
the effects of an experimental variable on a subset o f an organism's constituent 
parts. Currently, electroporation is one o f the most popular research tools used for gene 




single cell dissociation electroporation . gene delivery & m a ss  exchange




ions (e g . Na. K)
lipids reorganization & transient pores formation
+
•+ +  + + +
Figure 2-5: In vitro electroporation processes.
Generally, cells are mixed with genetic plasmids and suspended in the appropriate 
medium. After being loaded between two electrodes, a typical electroporation process 
will be experienced. After the cell polarization and genetic plasmids and mass exchange 
as descripted previously, cells will be collected and cultured for further observation or 
treatment.
2.2.6 Laboratory Practice 
The electroporation device is named electroporator. Components include a pulse 
generator, electroporation cuvettes and cuvette holder. Figure 2-6 showed the pulse 
generator, electroporation cuvettes and cuvette holder used in the experiment. A glass or 
plastic cuvette has two aluminum electrodes in a parallel manner on its sides. For 
electroporation operation, the voltage and capacitance will be set. The cell suspended in
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medium will be pipetted into the cuvette. Electric pulse will be given after the cuvette is 
inserted into the holder.
Figure 2-6: Electroporator BTX 830 (https://www.btxonline.com/ecm-830-square- 
wave-electroporation-system/).
2.2.1 Electroporation Cuvettes Electrodes Material 
As they directly contact with biological samples, the choice o f electrodes is 
extremely important in electroporation. Materials change along with the development of 
electroporation. Initially, aluminum or stainless-steel was chosen. Since the solution 
worked in the environment, metal ion might be released. It is seen as harmful for cell 
viability. The conventional electroporator uses platinum, gold or inert metal coated 
material as the electrodes. The cost o f manufacturing or the shedding of the coated 
material turns into another focused issue. Recently, due to the good bio-compatibility and 
low manufacture expense, conductive carbon material becomes a new hot research topic.
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High molecular weight organic material carbonization process is the pathway to 
fabricate conductive carbon material. Carbonization is the process by which solid 
residues with a high content o f carbon are obtained from organic materials. Through the 
pyrolysis process, polymer materials will decompose and gain new desired properties. 
Different precursors to glass-like carbon exist. The degree of shrinkage and carbon yield, 
the ratio o f the weight o f carbon to the weight o f the original polymer sample, varies 
depending on the choice.
2.3 Carbonization
2.3.1 Glass-Like Carbon
Glass-like carbon is obtained from pyrolysis, or derived from the thermal 
degradation process. Since it is an organic polymer material, inert atmosphere during 
pyrolysis is a necessary condition. After carbonization, the product is carbon and it is 
generally smooth, glossy and exhibits a conchoidal fracture. It is referred to as glass-like 
carbon. As an allotrope o f carbon, glass-like carbon has a very high isotropic in its 
structure and physical properties while liquid and gas permeability is very low. As for its 
crystal structure, until now, scientists have different opinions, but the most widely 
accepted model is the tangles and ribbon wrinkle aromatic molecules randomly cross- 
linked carbon - carbon covalent bond (Jenkins & Kawamura, 1971; Pesin, 2002). Like 
some non-continuous graphene fragments, this structure reflects the thermosetting resins, 
usually used as structural features o f the carbon precursor.
In addition, this model can also explain the most characteristic glass-like carbon 
by existing detection means such as its impermeability, brittle and conductivity (Jenkins 
& Kawamura, 1971; Pesin, 2002; Jenkins et al., 1972; Kakinoki, 1965). Here, we want to
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emphasize one thing even though we still cannot describe the exact structure o f glass-like 
carbon, and its structure is called glassy and amorphous, but it is not an amorphous 
carbon. The International Union o f Pure and Applied Physics (1UPAC) has defined the 
amorphous carbon as carbon materials with localized ji-electrons (Fitzer et al., 1995).
Glass-like carbon has become popular because it has a very reliable performance. 
With strong acids (sulfuric acid, hydrofluoric acid) and a corrosive chemical attack, such 
as bromine, it showed significant inertia. This point indicates that it is very stable. It may 
be oxidized in the presence o f oxygen under high temperature environment; however, 
tests showed that the oxidation rate compared to other carbon allotropes are much lower. 
From electrochemical point o f view, it even has a wider stability window than platinum 
and gold, which makes it a very suitable alternative to platinum and gold and other 
precious metals in electrochemical experiments (Zittel & Miller, 1965; Linde et al.,
1980).
In the mechanical properties, glass-like carbon has the same outstanding 
performance. The Young’s modulus range between 10 and 40 GPa and features 6-7 
Mohs, a value comparable to the hardness o f quartz, and its density stays between 1.4 and
1  n
1.5 g/cm , compared to graphite o f 2.3 g/cm (Yamada & Sato, 1962). This slight 
decrease drives scientists to speculate that perhaps there are some closed pores in the 
internal structure o f glass-like carbon. X-ray diffraction studies proved this speculation; 
there is a very small (about 50 A) pore structure inside the glass-like carbon (Rothwell, 
1968; McFeely et al., 1974). In thermodynamics, the thermal expansion coefficient o f the 
glass-like carbon is 2.2-3.2* 10~6/K, similar to some o f the borosilicate glass. It is also 
considered to be thermally inert. Its thermal conductivity is about one tenth o f the value
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of the typical graphite (Pesin, 2002; Pesin & Baitinger, 2002; Yoshida et al., 1991; Spain, 
1981; Ranganathan et al., 2000).
2.3.2 Temperature and Pressure Factors for Carbonization 
The process o f carbonization can be seen as the elimination process o f different 
hydrocarbons and gases, as shown in Figure 2-7. Most o f these reactions are closely 
related to the temperature and pressure. Modifying temperature and pressure is the key 
point to have a good control o f the carbonization process. The application o f pressure in 
certain temperatures can prevent the carbon atom from being released during the gas 
phase (particularly hydrocarbon gases). Detaining carbon atom in the final products can 
improve the carbonization yield rate. Mechanical and chemical properties such as 
solubility, viscosity, and density can also be modified. In addition, carbonization under 
pressure is also expected on the possibility o f controlling the phase change on carbon 
allotrope to obtain specific particle morphology of the resultant carbons.
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Figure 2-2: Carbonization process [book: Advanced Materials Science and 
Engineering of Carbon]
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Carbonization under pressure has been classified into three routes: carbonization 
under built-up pressure by decomposition gases from carbon precursors, hydrothermal 
conditions, and the reduction o f CO2 under pressure. Under pressure built up by the 
decomposition gases from carbon precursors, such as pitches, the acceleration of the 
formation o f mesosphere spheres was confirmed and their coalescence was suppressed at 
a temperature a little higher than under atmospheric pressure, even though their 
coalescence could not be inhibited. A marked increase in carbonization yield was 
observed on all precursors, suggesting that the evolution o f hydrocarbon gases from the 
organic precursors was strongly suppressed during pyrolysis and carbonization. However, 
it has to be pointed out that an efficient increase in carbonization yield was possible only 
in the sealed capsule (closed system) where all decomposition gases were included in the 
capsule. When the capsule was open, even in the autoclave, a marked improvement in 
carbonization yield was not observed in most cases because the decomposition gases 
were deposited on low-temperature parts o f the autoclave. In order to get carbon 
materials from polyethylene, which does not give any carbon residues under atmospheric 
pressure, the whole o f the autoclave itself had to be heated to a high temperature.
Different carbon materials, carbon nanotubes, fullerenes, diamond, and carbons with 
various morphologies, were often formed as a mixture. However, carbon materials with 
spherical morphology (carbon spheres) were synthesized without appreciable amounts of 
other forms of carbon by selecting the conditions o f pressure carbonization. On the basis 
o f the results published, the formation conditions o f single carbon spheres with different 
nanotextures are discussed here with relation to the temperature-pressure conditions and 
also the chemical composition o f the precursors.
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The pressure and temperature ranges for carbonization process are shown in 
Figure 2-8. The spherical morphology of carbon materials has been reviewed, focusing 
on their nano texture and preparation processes (Davis et al., 2004). Carbonization of 
different organic precursors in the atmosphere o f their decomposition gases has been 
carried out in relatively limited ranges o f temperature (500-700°C) and pressure (50-250 
MPa). In supercritical water, carbon spheres were obtained from benzene at a slightly 
lower temperature o f 400°C by adding a small amount o f H2O2 as an initiator o f radical 
reactions. Under hydrothermal conditions, pressure carbonization o f saccharides occurred 
at an even lower temperature o f 200°C to give carbon spheres that still contained 







|  150 
£
- • • fUsiakm of CO, bj Cm 
OS-M pa v
100 -
0 200 400 600 800 1000 1200 1400
Tfempermturc/XT
Figure 2-8: Pressure-temperature Conditions for the Formation o f Carbon Spheres 
from Different Precursors. [Book: Advanced Materials Science and Engineering o f 
Carbon]
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2.3.3 Composition of Precursors 
The carbonization behavior o f the carbon precursor changes under pressure and 
the resultant carbon is different in structure, properties, and even particle morphology 
from that obtained without pressure. The departure o f various hydrocarbons and carbon 
oxides results in the loss o f carbon atoms from the precursor; in other words, it lowers the 
carbonization yield.
CHAPTER 3
MICRO-PILLAR ARRAY ELECTROPORATION TO ENHANCE 
GENE DELIVERY TO MAMMALIAN CELLS
3.1 Introduction
A number o f new systems with micro-/nanoscale features have recently been 
introduced to tackle the high-voltage issues through closely patterning electrode pairs 
and/or sophisticatedly focusing the electric pulses (Kim et al., 2007; Huang et al., 2014). 
The rationale behind these microelectroporation concepts comes from the fact that when 
the two electrodes are brought very close, e.g. -2 0  pm, a low voltage (1-2 V) is sufficient 
to generate pulses with a high enough field strength (e.g., 500-1000 V/cm) required for 
successful cell electroporation. The micro/nanoscale pathways that stand between 
electrodes could further concentrate the applied electric pulses (Wang et al., 2008). These 
micro-devices opened new routes towards the elimination of many induced apoptosis of 
electroporation and indeed offer several advantages over commercial systems (Wang & 
Lee, 2013).
However, most of these micro-electroporation systems still ignore the local 
electrical variations on individual cells o f a large population, leaving many uncontrollable 
factors similar to that in the bulk electroporation systems. For example, according to 
Equation 1, the needed transmembrane potential is not only related to the field strength,
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but also the size and electrical properties o f the treated cells. Unfortunately, this issue did 
not attract enough attentions in the past due to the lack of simple but effective tools.
In this chapter, we propose a much more efficient gene delivery method, called 
the Micro-pillar Array Electroporation (MAE) approach to accomplish size specific 
electroporation. We loaded cells on a pre-treated micro-pillar array structure. By placing 
a piece o f conductive plain plate surface on the top, we applied a low voltage pulse to 
achieve temporarily dielectric breakdown of the cell membrane and gene delivery. We 
observed a significant improvement o f gene transfection with minimal cell damage.
Unlike some pioneer work in which a few micro- or nanoscale pillar electrodes 
were used as the replacement o f capillary electrodes to monitor the intracellular electrical 
signals o f single or a few cells for electrophysiology study (i.e., SCE) (Spira & Hai,
2013; Xie et al., 2012), this new MAE setup utilizes well-patterned, large-scale (center- 
meter size) micropillar array to achieve size specific treatment to cells of a large 
population (i.e., BE) for the efficient uptake o f an exogenous payload. In fact, it works 
like many SCE units that are carried out in parallel with no need for cell positioning. As 
every cell electroporation becomes representative, the cellular uptake dynamics study on 
individual cells in MAE might provide useful information in electroporation protocol 
identification for unknown cell sources (e.g., primary cells). Therefore, it has the 
potential to facilitate the communication between SCE (for cell electrophysiology study) 
and BE (for large scale gene transfection tests) to leverage the current electroporation- 
based delivery technology. In this contribution, we evaluated its transfection 
enhancement o f reporter genes (pMaxGFP and gWizLuc). Both anchor cells (e.g., NIH
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3T3 and A549 cells) and suspension cells (e.g., K562 cells) were tested to demonstrate its 
broad effectiveness.
3.2 Materials and Methods
3.2.1 Materials and Reagents
DNA plasmids with gWiz Luciferase and pMax GFP reporter genes were 
purchased from Aldevron, Inc. and Lonza, Inc., respectively. All other chemicals were 
purchased from Sigma-Aldrich and the cell culture reagents were purchased from Life 
Technologies (Carlsbad, CA) unless specified.
3.2.2 Cell Culture
NIH/3T3 cells (ATCC, CRL-1658) were routinely grown and maintained in high 
glucose DMEM supplemented with 10% newborn calf serum (NCS), 1% penicillin and 
streptomycin, 1% L-glutamine, and 1% sodium pyruvate. K562 cells (ATCC, CCL-243) 
and A549 (ATCC, CCL-185) were cultured in RPMI 1640 supplemented with 10% NCS, 
100 pg/mL penicillin, 100 pg/mL streptomycin, and 100 pg/mL L-glutamine. All cultures 
were maintained at 37°C with 5% CO2 and 100% relative humidity.
3.2.3 Micropillar Array Electrode Fabrication
Micropillar arrays were fabricated by BioMEMS technologies. Briefly, SU-8 
photoresist was patterned on a Si (100) wafer via photolithography. Micropillars o f 2 or 6 
pm in diameter and a pitch size o f 2 pm (Figure 3-2b) were defined in several 12-mm 
disc regions (Figure 3-1).
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Figure 3-1: Schematic o f the micropillar array electrodes integrated with the SU-8 
spacer and connecting the microchannel in MAE.
The actual height o f the finished micropillars was found to be ~4 pm. Conductive 
micropillars were made by sputter coating with gold (for gold coated micropillar 
electrode). A second SU-8 layer was then applied to cover the non-electrode area and 
define two 100-pm long, 20-pm wide connecting channels to the micropillar array 
chamber, one on each side (Figure 3-1). When the cell solution drop is squeezed to fill
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the entire micropillar chamber, the extra solution is guided into these channels and push 
air out to avoid potential bubble trapping issues during the chamber closure. Ball wire 
bonding was applied to connect the microelectrodes to wires that were plugged to a pulse 
generator (BTX 830).
3.2.4 Measurement o f the Gap Size o f Electrodes in MAE 
As the sealing o f the liquid chamber between the two electrodes in the MAE 
system and “Au plain plate” systems was done by a PDMS gasket, some deformation 
occurred when the top micropillar electrode was firmly pressed down for closure. 
Therefore, the actual gap size between the two electrodes was smaller than the sum of the 
measured thickness o f the epoxy spacer (10 pm) and the PDMS gasket (200 pm). To find 
out the actual distance between the two electrodes, we measured the amount o f excess 
liquid in the connecting channels that was squeezed out o f the liquid chamber when the 
two plates were closed (see Figure 3-2). The actual gap size was then calculated based on 
the total volume of the loaded cell solution and the dimensions o f the liquid chamber and 
the connecting channels:
where D is the diameter o f the liquid chamber, W is the width o f the connecting channel, 
L is the length o f the liquid connecting the channel, and H is the height o f the gap 
between the two electrodes (Figure 3-2). The gap size, H, is then calculated by:
Ktotal cell solutior cell solution in liquid cham ber cell solution in connecting channel






3.2.5 Device Assembling 
In MAE, cells will be sandwiched between a plain plate electrode and a plate 
electrode composed o f thousands o f micropillars in a well-patterned array format. In this 
way, the number o f micropillars in each cell varies with its membrane surface area, or the 
size o f the cells, as schematically shown in Figure 3-2.
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Figure 3-2: The working principle o f the micropillar array electroporation (MAE), (a) 
Schematic o f the cell size-specific treatment mechanism (large cells face more 
micropillars with each providing focused electric pulse during electroporation); (b) a 
SEM image o f 2-pm micropillars; (c) schematic illustration o f MAE operation.
In other words, larger cells likely receive more electroporation locations and area, 
which means more transient pores are created on their cell membrane with each smaller 
pore. Such size dependent pore formation mechanism is hardly affected by the random 
dispersion fact o f cells as micro-pillars are configured in a well-patterned large array.
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3.2.6 Electroporation Setup and Process
Cells were first centrifuged and re-suspended in fresh OPTI-MEM I (a serum free 
medium) at a density o f 0.5 x 106 cells/ml. Plasmid DNA (pGFP or pLuc) o f 10 pg was 
then added to make the electroporation sample solution. In MAE electroporation (Figure 
3-2c), a piece o f gold or carbon coated plate electrode with a PDMS gasket o f 200 pm in 
height was first mounted on a mini mechanic press. One drop o f cell solution (20 pL) was 
then loaded into the formed liquid holding chamber. The micropillar array electrode, 
mounted on the other plate of the press, was loaded down to squeeze the liquid drop until 
the edge o f the pre-defined SU-8 spacer (-10 pm) surrounding the micropillars firmly 
touched the PDMS gasket to seal the liquid chamber. The SU-8 spacer protects 
micropillars from destruction and controls the gap between the two electrodes o f MAE. A 
single, 10-ms electric pulse o f 10V was then applied across the two electrodes for 
electroporation. For comparison, standard electroporation was also done using a 
commercial BTX system (ECM 830, Flarvard Apparatus). Samples o f 100 pL each were 
loaded into 2-mm electroporation cuvettes and a standard electroporation protocol (125 V, 
single 10-ms pulse) was applied. As the measured gap size between the two electrodes of 
MAE system is -160 pm, this is designated to ensure that the overall electric field 
strengths are the same (625 V/cm) in all three systems. After treatment, cells were 
transferred to 6-well plates and cultured for another 24 hours and then harvested for 
analysis.
3.2.7 Transfection Efficiency and Cell Viability
The expression o f pGFP plasmids was evaluated both qualitatively by visualizing 
cells with green fluorescence within some representative areas under an inverted
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fluorescence microscope (Olympus, Japan) and quantitatively by counting cells using an 
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). The fluorescence 
intensity o f GFP was measured using the Cell Assay Module with live cells stained with 
carboxy-naphthofluorescein (CBNF). The results were analyzed with Agilent 2100 
Expert Software and 500-1,500 events were counted for each sample. The transfection 
efficiency of pGFP is defined as the number o f cells emitting fluorescence signal to the 
total number o f cells in a sample (gated fluorescence signal of GFP). The Luciferase 
expression was quantified by One-GloTM Luciferase assay system (Promega, Madison, 
WI). One-GloTM reagent o f 100 pL was added to the cell growth medium of 100 pL in 
96-well plate. Luminescence was measured with a plate reader (FLUOstar OPTIMA, 
BMG LABTECH, Germany) after 10 min incubation at room temperature for complete 
cell lysis. The transfection efficiency of pLuc is presented as the luminescence of the 
total live cells in a sample.
The cell viability was evaluated by an MTS cell proliferation assay (Promega, 
Madison, WI). Briefly, the cells in 100 pL/well o f the medium were transferred to a 96- 
well plate and incubated. CellTiter 96 AQueous One solution (Promega, Madison, WI) of 
20 pL was added to each well and all samples were incubated at 37°C for another 4 hours. 
Absorbance was measured at 492 nm on an automated plate reader (Elx 800, Biotek, VT). 
Data points were represented as the mean ± standard deviation (SD) o f triplicates, unless 
otherwise indicated. The cell viability is calculated as the ratio o f light absorbance o f an 
electroporated cell sample to that o f the negative control cell sample in MTS assay 24 
hours post electroporation.
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3.3 Simulation on the Electric Field of MAE
COMSOL (Mathworks, MA) was used to calculate the electric field in MAE 
based on a finite-element method (FEM). We considered an axial symmetric model with 
one micropillar (2 or 6 pm in diameter) and a single cell (d = 16 pm) in the computation 
domain (35 pm x 21 pm). An electric field (E = 625 V/cm) was assigned across the top 
and bottom o f the computation domain whose right side boundary was set as the insulated 
wall. The cell was placed at the center of the left side boundary (the symmetrical axis) 
and a three-layer cell model, divided as the external medium, the cell membrane (5 nm in 
thickness), and the cell cytoplasm, was setup (Stewart et al., 2005; Fei et al., 2010). A 
gold micropillar was placed at the top of the cell, 0.5 pm and 1.0 pm away from the cell 
and the symmetrical axis, respectively. With a pitch size o f 2 pm, cell membrane 
deformation in the gap of the micropillars seems essential (Kulangara et al., 2012). 
Therefore, a quarter-circle raised arch (with a radius o f 0.5 pm) was created on the cell 
membrane close to the micropillar to mimic its deformation. Detailed model dimensions 
and mesh setup are illustrated in Figure 3-3. The electric potential distribution around the 
micropillar and the cell was calculated. In this three-layer cell model, the electrical 
conductivity o f the buffer, the cytoplasm, the membrane, and the gold-coated micropillar 
was set as 0.8, 0.2, 5* 1 O'7, and 4x 107 S/m, respectively.
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Figure 3-3: The model geometry and mesh setup for the electric field simulation o f a 
single micropillar protruding towards a single cell. Location “A” is the chosen point in 
later transmembrane potential calculation.
3.4 Results and Discussion
3.4.1 Enhancement o f MAE on reporter gene transfection 
We first did MAE electroporation on 3T3 cells and K562 cells for DNA plasmid 
delivery. For comparison purposes, electroporation using both a commercial system 
(designated as “BTX) and another configuration with two closely placed plain electrodes 
but no micropillar pattern (designated as “Au Plain Plate”) was also done in conjunction. 
Successful transfection was observed in all three cases with many cells expressing green 
fluorescence protein (GFP) (Figure 3-4 and Figure 3-5a). Their quantitative difference on 
GFP-positive cells was further measured. As shown in Figure 3-5b, the transfection 
efficiency with two closely placed plain plate electrodes (43.6 ± 1.6% for K.562 cells and 
44.1 ± 1.8% for 3T3 cells) is generally much better them that from BTX (K562: 25.7 ± 
1.8%, 3T3: 25.4 ± 3.6%). When micro-pillar array is introduced on the electrode surface,
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the transfection percentage is further improved (K562: 70.3 ± 2.5%, 3T3: 65.1 ± 3.7%). 
These results confirm the enhancement o f MAE on plasmid transfection for mammalian 
cells and the improvement is indeed attributed to both the micro-pillar features and the 
closely placed electrode configuration. Some loss on the cell viability (-10-15%) is 
observed, but not statistically significant (Figure 3-5c). This is not surprising considering 
the actual voltage used in current MAE setup (10 V) is still beyond the threshold for 
electrochemical hydrolysis o f water (-1.3 V). Its negative impact on cell survival is 
minimized, but not completely avoided.
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Commercial electroporation (BTX)
Close-patterned plain plate electroporation
MAE electroporation
Figure 3-4: Fluorescence and phase contrast microscopic images o f pGFP plasmid 
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Figure 3-5: Transfection enhancement o f pGFP plasmids in 2-pm micropillar MAE. 
(a) Phase contrast and fluorescence microscopic images o f NIH 3T3 cells after 
transfection by a commercial system (“BTX”), “Au plain plate”, and MAE; 
quantitative results o f transfection efficiency (b) and cell viability (c) for 3T3 cells and 
K562 cells, respectively. (**) represents p < 0.01, (***) represents p < 0.005, (****) 
represents p < 0.0001.
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Such transfection enhancement is attributed to the synergistic effects o f the 
electric field focusing, localized electroporation, and size-dependent treatment in MAE. 
The first two effects benefitted cell membrane permeabilization at benign pulse 
conditions and its better recovery afterwards, while the size-dependent treatment 
allocates the number and area o f the transient openings on individual cell membrane to 
ensure homogeneous treatment on cells o f various sizes. Their specific contributions are 
discussed in the following sections.
3.4.2 Focusing o f the Electric Pulses 
Like what occurs in many micro/nanofluidic electroporation proof-of-concepts, 
micropillars in MAE help focus the electric field with their microscale at the far end that 
protrudes towards the cell membrane (Figures 3-6a-3-6b). According to the continuity o f 
the electric field, the focusing level depends on the surface area (or size) o f the 
micropillars. As the focused electric pulses affect mainly a tiny portion o f the cell 
membrane that each micropillar faces, this gives additional localized electroporation 
benefit on the subjected cell. However unlike micro/nanofluidic electroporation, MAE 
does not require fluidic components to trap cells to accomplish these benefits. Its 
operation is therefore more compatible and similar to the commercial electroporation 
systems. As demonstrated by the COMSOL simulation (Figure 3-6c), the transmembrane 
potential near the micropillar is much higher than that without micropillar when the 
overall field strength is held constantly at 625 V/cm for all three cases. As a consequence 
o f high transmembrane potential, these locations are more inclined to form temporary 
openings than elsewhere on the cell membrane during electroporation.
(a) <b) (c)
Figure 3-6: COMSOL simulation of the calculated electric potential and field lines 
around a cell facing an “Au plain plate” electrode (a) and a 2-pm micropillar (b). (c) 
The calculated transmembrane potential at location “A” (marked in Figure 3-3) o f the 
cell.
3.4.3 Cell Size-Dependence Transfection 
The number o f induced pores and the transient permeable area on the cell 
membrane varies with the size o f individual cells when the design of the micropillar 
array is fixed. With well-patterned array configuration, such size-dependent treatment 
o f MAE is not affected by the randomly located sites o f the cells. In other words, a big 
cell faces more micropillars and should have more porated locations and larger 
permeable areas to facilitate cellular uptake. To verify our hypothesis, the transgene 
expression of pGFP inside individual cells was measured, together with the cell size 
using NIH Image J. According to our size specific electroporation rationale, the size 
o f the cells has a constant correlation to the number o f micropillars they face, 
regardless their random dispersion. Therefore, the cellular uptake o f DNA plasmids 
for cells o f different sizes also represents similar relation to the number o f 
micropillars they have faced early.
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As shown in Figure 3-7a, despite the large scattering o f data, the GFP intensity 
clearly shows a proportional increase with the cell size, particularly for large cells (> 
10 pm). Different from the BTX system whose GFP signal is accumulated mainly in a 
specific size range (< 12 pm), the signal from MAE is stronger and extends to a 
broader size range. Similar trends are also observed in the dot-plots o f the flow 
cytometry results (Figures 3-7b and 3-7c). This suggests that MAE works effectively 
fir cells of many different sizes, unlike the commercial system which works best for 
cells o f certain size populations. This is reasonable as the recommended 
electroporation protocols for most commercial systems are generally identified by a 
trial-and-error process and the optimal performance must be tied with effective 
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Figure 3-7: The plot o f fluorescence intensity o f GFP in transfected K562 cells to the 
cell size in a commercial bulk electroporation system (“BTX”, panel a and b) and a 2- 
pm micropillar MAE system (a, c).
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3.4.4 Effect o f Size and Density o f Micro-pillars on Electroporation Enhancement 
Besides the cell size, the dimensions o f individual micropillar and their pitch size 
in the array also decide the number o f micropillars each cell faces and the consequent cell 
transfection. To simplify the case, we fabricated micropillars o f two different diameters 
(6 pm and 2 pm) with a fixed pitch size (2 pm). As shown in Figure 3-8a, K.562 cells 
face -2-4  6-pm micropillars on average (full coverage) with a maximum of 6-9 
micropillars (partial coverage) for some giant cells. Many covering events are incomplete 
and heterogeneous, largely depending on the actual size o f the cells and their settling 
locations on micropillars. As a comparison, on 2-pm micropillar electrode, more 
micropillars cover each cell (with as many as 16 for some large cells) and incomplete 
coverage is hardly observed despite the random location o f cells. Therefore, the cell 
coverage on 2-pm micropillars varies more constantly with the actual size o f the 
individual cells. As a consequence, the number o f locally porated openings and the total 
permeable area on the cell membrane should become more size specific and the DNA 
delivery dosage to cells o f various size populations are improved. As demonstrated in 
Figure 3-8b, the transfection efficiency o f 2-pm micropillar MAE is -65%  and -70%  for 
3T3 cells and K562 cells, respectively, while only -55%  and -59%  for those using 6-pm 
micropillars, though both were much higher than the one using 2-mm cuvettes (-25%). 
This additional gain on the transfection efficiency is believed to be the result o f more 
accurate allocation of the pulse on the cells based on their size in 2-pm micropillar MAE. 
Its electroporation works more effectively to cells o f different sizes than the 6-pm ones 
and accomplishes better transfection performance.
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Figure 3-8: The effect o f micropillar size and density on MAE electroporation 
enhancement, (a-b) Phase contrast images o f cell coverage on 6-pm micropillar array 
(a) and 2-pm micropillar array (b); the comparison on the enhancement performance 
for MAE based on micropillars o f various sizes: transfection efficiency (c) and cell 
viability (d). (**) represents p < 0.01, (***) represents p < 0.005.
3.5 Conclusions
We developed a micropillar array electroporation (MAE) platform and evaluated 
its contributions to the delivery efficiency of DNA probes with both anchor cells and 
suspension cells. The well-defined micropillar array ensures size specific treatment to a 
large number o f cells regardless o f their various sizes and random dispersion states. The 
close-configured microelectrodes allow low-voltage pulse conditions for electroporation 
through focused pulse strength and localized poration to the cell membrane. The delivery 
efficiency was evaluated with both model anchor cells (i.e., NIH 3T3) and suspension
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cells (i.e., K562), together with their impact on cell viability. The advantages o f this 
MAE system varied with the number, size, and density o f the micropillars while its 
electroporation performance was similar for both gold-coated and carbon-based 
micropillar electrodes.
Although more DNA probes were introduced and the expression level o f certain 
proteins were largely regulated, no significant increase o f toxicity was found when 
compared to a commercial electroporation system. Besides the benefits o f this MAE 
system demonstrated here, our design might help bridge two important, but long 
separated electroporation fields: single cell electroporation and cell electroporation o f a 
large population (bulk electroporation). This system, as evidenced for its great 
improvement on DNA delivery efficiency, could also facilitate the discovery on cellular 
uptake dynamics and electroporation mechanism. Its success may help simplify the 
tedious, cell-specific protocol searching process and benefit the whole life science and 
biomedical community where a safe and effective non-viral gene delivery approach is 
needed on a daily basis.
CHAPTER 4
CARBON ELECTRODE MICRO-PILLAR ARRAY 
ELECTROPORATION
4.1 Introduction
Electroporation, known as a physical gene delivery method, is widely used for 
breaking the primary barrier, cell membrane, to achieve the transport o f molecules and 
ions between the interior and the exterior o f a cell. Since the early 1980s, conventional 
electroporation is typically applied in short electric pulses in a certain intensity and 
duration to a cuvette embedded with electrodes inside. In the parallel manner, the 
electrode materials are usually aluminum, stainless-steel, platinum, gold and/or graphite.
The last chapter describes the benefits brought from the introduction o f the micro 
structure electroporation system. The micron structure o f the electrode was processed by 
thermal evaporator to evaporate a layer of inert metal on the micron pillar array. This 
treatment is a very good solution to solve the problem of non-conductive organic 
polymer. However, there are some problems that emerged gradually in the actual 
operation.
One is the persistent problem of the device. Although thermal evaporation can 
coat metal uniformly on the substrate surface, the binding between inert metal and 
organic polymer in repeated use will be challenged. In the laboratory environment, after 
multiple uses (5-10 times), we can clearly observe the phenomenon of falling metal.
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Although subsequent equipment preparation introduced an annealing process to 
reduce the internal stress o f the metal works, the improvement was not obvious. On the 
other hand, since the surface o f the conductive layer after multiple uses shed the problem, 
equipment reliability considerations reintroducing conductive layer is a necessary means. 
However this naturally raises consideration of production costs. Based on the above, to 
find a reliable way to introduce the conductive layer, the preparation cost can be reduced.
In this chapter, we combined our MAE system with conductive carbon material. 
With the same device structure used in Chapter 3, we attempted different fabrication 
method on electrode material. We loaded cells in a micro-scaled channel. We evaluated 
its transfection enhancement o f reporter genes (pMaxGFP and gWizLuc). Both anchor 
cells (e.g., NIH 3T3 and A549 cells) and suspension cells (e.g., K562 cells) were tested to 
demonstrate its broad effectiveness. A significant improvement o f gene transfection and 
excellent bio-competitive were expected. Additionally, small interfering RNA was tested 
to demonstrate its broad effectiveness.
4.2 Materials and Methods
4.2.1 Materials and Reagents
Small interfering RNA (siRNA) used for silencing GFP (expressed by pMaxGFP) 
and Luciferase genes were synthesized by Thermo Scientific (Pittsburgh, PA) and the 
sequences were as follows: siRNA for GFP silence, sense strand, 5’- 
CGCAUGACCAACAAGAUGAUU-3’; antisense strand, 5’- 
UCAUCUUGUUGGUCAUGCGGC-3’; Luciferase GL3 Duplex (Luc-siRNA), sense 
strand, 5’-CUUACGCUGAGUACUUCGA-3’; antisense strand, 5’- 
UCGAAGUACUCAGCGUAAG-3’. All other chemicals were purchased from
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Sigma-Aldrich and the cell culture reagents were purchased from Life Technologies 
(Carlsbad, CA) unless specified.
4.2.2 Cell Culture
NIH/3T3 cells (ATCC, CRL-1658) were routinely grown and maintained in high 
glucose DMEM supplemented with 10% newborn calf serum (NCS), 1% penicillin and 
streptomycin, 1% L-glutamine, and 1% sodium pyruvate. K562 cells (ATCC, CCL-243) 
and A549 (ATCC, CCL-185) were cultured in RPMI 1640 supplemented with 10% NCS, 
100 pg/mL penicillin, 100 pg/mL streptomycin, and 100 pg/mL L-glutamine. All cultures 
were maintained at 37° C with 5% CO2 and 100% relative humidity.
4.2.3 Small Interfering RNA
In this chapter, with carbon electrode fabricated, another genetic particle called 
small interfering RNA was tested. Small interfering RNA (SiRNA) was first discovered 
by David Baulcombe's group and reported about 15 years ago (Hamilton & Baulcombe, 
1999). It has a well-defined structure, double-stranded RNA molecules with 20-25 base 
pairs. In the past 15 years of research, SiRNA can play many roles in today’s laboratory. 
However, the most frequency used is the RNA interference (RNAi) pathway. SiRNA 
functions are also known as a silencing RNA. It can lead to mRNA transcription breaking 
down. It interferes with the expression of specific genes and results in no translation.
Here, we evaluated its transfection enhancement o f reporter genes (pMaxGFP and 
gWizLuc) and their corresponding siRNAs. Both anchor cells (e.g., NIH 3T3 and A549 
cells) and suspension cells (e.g., K562 cells) were tested to demonstrate its broad 
effectiveness.
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4.2.4 Micro-Pillar Array Fabrication
Micro-pillar arrays were fabricated by MEMS technologies. SU-8 photoresist was 
applied on a Si (100) wafer and the pattern was transferred from a Cr photomask via the 
photolithography process. Micro-pillars with a pillar size o f 2 or 6 pm and a pitch size o f 
2 pm (Figure 3-lb) were defined in many 6-mm radius disc regions (Figure 3-lc). The 
photo-lithography was processed as follow:
1. Wafer was cut into small 1 by 1 inch squares by a dicing saw 
(Microautomation).
2. Cleaning. Typically, the wafers were prepared by soaking in acetone, 
isopropyl alcohol, and rinsed by deionized water (D1 H2O). Since the dicing step 
introduced contamination, a standard RCA clean procedure was applied. The silicon 
wafer was immersed in the following solutions according to priority and are thoroughly 
rinsed with deionized water and dried by air between each step.
• SC-1: to remove organic contamination and particles
DI H2O : ammonium hydroxide (NH4O H ): hydrogen peroxide H2O2 = 5:1:1 At 
80°C, for 10 minutes.
• Buffered oxide etchant (BOE): while the SC-1 step removed organic 
contamination and particles, a thin layer would form of silicon dioxide on the wafer’s 
surface. The BOE is for removing the oxide layer.
Hydrofluoric acid (H F ): ammonium fluoride (NH4F) = 1:7 At 25°C, for 1 minute.
• SC-2: to remove ionic and metallic contamination
DI H2O : hydrochloric acid (HC1): H2O2 = 5:1:1 At 80°C, for 10 minutes.
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3. Pre-bake. After cleaning, the wafer was baked on the hot plate at 180 °C
%
for about 15 minutes to remove the residual water on and inside o f the wafer.
4. Photoresist (PR) application. Both Shipley Microposit S 1800 series 
positive photoresist and MicroChem SU 8 - 2000 series permanent epoxy negative 
photoresist were used for patterning the pillar structure. The wafer was placed on resist 
spinner (CEE, model 100 programmable). According to the thickness requirement 
adjusted, the spin rate was from 800 to 5000 rpm for 30 - 120 seconds. The PR would 
form a uniform thin layer and usually with uniformity within the range o f 5 to 10 
nanometres.
5. Soft-bake. Soft-bake process is the most important step o f the 
photolithography technology. After PR application, in the layer o f the resist, it contains a 
remaining solvent concentration depending on the resist, the solvent, the resist film 
thickness, and the resist coating technique. The soft-bake can reduce the remaining 
solvent content. It is important because o f the following reason:
• avoid mask contamination and/or sticking to the mask,
• prevent popping or foaming o f the resist by N2 created during exposure,
• improve resist adhesion to the substrate,
• minimize dark erosion during the developing process,
• prevent prior coated layer dissolving from the following photoresist 
coating,
• extrude bubble for the following process.
The soft-bake temperature and time varies up to the PR. Typically for S I813, it is 
in the range o f 90 to 100°C and 30 to 60 seconds on a hotplate. For the SU-8, it depends
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on the thickness o f the coating. A longer and slower heating is required for a thicker layer 
o f resist.
6. Exposure. After soft-bake, the photoresist is exposed under an intense 
light resource. EV 420 Mask Aligner (ELECTRONIC VISIONS) was used for aligning 
the mask and wafer together. Exposure time is calculated by the equation:
Dose = Intensity { m W / c m 2) * Exposure tim e (s)
7. Post-exposure bake (PEB). A post-exposure bake (PEB) is performed after 
exposure. For SU-8 photoresist, PEB is necessary. It can reduce the interference patterns 
caused by the incident light. Wafer was baked on the hot plate at 95°C for about 3 
minutes.
8. Developing. By immerging the wafer into photoresist developer, the 
desired pattern or structure would emerge. Different photoresists should work in their 
specific developer. Presented in this dissertation, positive photoresist, 1813s, developed 
with MF 319 and negative photoresist, SU-8, developed in SU-8 developer. Due to the 
designed pattern size, photoresist applied thickness and exposure time, development time 
various.
9. Hard bake. A hard bake can be performed after development in order to 
increase the thermal, chemical, and physical stability of developed resist structures for 
subsequent processes such as electroplating, wet- and dry-chemical etching. Hereby, the 
following mechanisms have to be considered.
4.2.5 Carbonization
Carbonization is a complex process to produce conductive glass-like carbon. 
Polymer or organic compounds experience three major steps during pyrolysis process:
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pre-carbonization, carbonization and annealing. Each step plays a different role as shown 
in Table 1
Table 1: Different steps o f pyrolysis
Pre-carbonization (typically T < 300°C) Defecating molecules solvent and 
unreacted monomer from the polymeric 
precursor
Carbonization 300 to 500°C
Eliminating heteroatoms, such as oxygen 
and halogens, caused a rapid mass loss. 
The beginning of hydrogen atoms are 
eliminated. Rudiment carbon systems 
formed.
500 to 1200°C
completely eliminate heteroatoms 
(hydrogen, oxygen and nitrogen atoms) 
the aromatic network (carbon-carbon 
bond) is forced to connect, 
decreases: permeability, 
increase: Young’s modulus, density, 
hardness and electrical conductivity.
Annealing Stabilize carbon structural system and 
remove thermal stress.
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The final chemical constitution (carbonization and the residual heteroatoms) are 
determined by polymeric precursor and pyrolysis. Generally, 90% of the carbon content 
is expected in the residue at final pyrolysis temperature 900°C and more than 99% at 
1300° C (Rodrigo, 2014).
4.2.5.1 Micro-Pillar Array Electrode Carbonization Protocol. As described 
previously, micro-pillar array electrode was carbonized through a pyrolysis process. With 
our work, carbonization of negative SU-8 photoresist takes place in a tube furnace 
(structure shown in Figure 4-1) under a nitrogen preventing atmosphere (N2 flow at 2000 





Figure 4-1: Carbonization set up used for produce conductive carbon material 
(http://www.scielo.br/img/revistas/mr/2012nahead/aop_l 346fig01 .jpg).
Samples were loaded on the sample holder at the midpoint o f the quartz tube. 
Different protocols were tested to figure out the appropriate procedure generating the best 
mechanical and electrical properties. Table 2 lists primary tested protocols with a brief 
result. All protocols started at room temperature (RT). Temperature is the form of Celsius. 
Figure 4-2 shows images from protocols I (a); II (b) and III (c).
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I RT—>280 in 60 min. 
Dwell 90 min.
280—>600 in 100 
min. Dwell 60 min. 
600—>900 in 100 
min. Dwell 60 min.
900—>600 in 100 
min. Dwell 60 min. 





II RT—>-200 in 18 min. 
Dwell 30 min.
200—>900 in 70 min. 
Dwell 60 min.
900—>RT in 60 min. Slightly
crack
III RT—>200 in 40 min. 
Dwell 60 min.
200—>900 in 0 min. 
Dwell 60 min.




IV RT—>200 in 40 min. 
Dwell 90 min.
200—>900 in 46 min. 
Dwell 60 min.






Figure 4-2: Images for pyrolysis protocols I (a); II (b) and III (c).
As shown in Table 2, the protocol IV was finally considered as standard pyrolysis 
process procedure for photoresist material SU-8. It is featured as three stages: (1) 
temperature from room temperature to 200°C at the heating rate o f 5°C/min, followed by 
a 30-min dwell at 200°C; (2) temperature from 200°C to 900°C with the rate o f 15°C/min 
with a one-hour dwell at 900°C to complete carbonization; and (3) a natural cool down to 
room temperature. This process was summarized and plotted in Figure 4-3.
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600  ̂ @5°C/min
Dwell 30 min @15°C/min
Dwell 60 min
Figure 4-3: Three stages of SU-8 carbonization protocol.
4.2.6 Transfection Efficiency and Cell Viability 
The expression o f pGFP plasmids was evaluated both qualitatively by visualizing 
cells with green fluorescence within some representative areas under an inverted 
fluorescence microscope (Olympus, Japan) and quantitatively by counting cells using an 
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). The fluorescence 
intensity o f GFP was measured using the Cell Assay Module with live cells stained with 
carboxy-naphthofluorescein (CBNF). The results were analyzed with Agilent 2100 
Expert Software and 500-1,500 events were counted for each sample. The transfection 
efficiency o f pGFP is defined as the number o f cells emitting fluorescence signal to the 
total number o f cells in a sample (gated fluorescence signal o f GFP). The Luciferase 
expression was quantified by One-GloTM Luciferase assay system (Promega, Madison, 
WI). One-GloTM reagent o f 100 pL was added to the cell growth medium of 100 pL in a
65
96-well plate. Luminescence was measured with a plate reader (FLUOstar OPTIMA, 
BMG LABTECH, Germany) after 10 min incubation at room temperature for complete 
cell lysis. The transfection efficiency o f pLuc is presented as the luminescence o f the 
total live cells in a sample.
The cell viability was evaluated by an MTS cell proliferation assay (Promega, 
Madison, WI). Briefly, the cells in 100 pL/well of medium were transferred to a 96-well 
plate and incubated. CellTiter 96 AQueous One solution (Promega, Madison, WI) o f 20 
pL was added to each well and all samples were incubated at 37°C for another 4 hr. 
Absorbance was measured at 492 nm on an automated plate reader (Elx 800, Biotek, VT). 
Data points were represented as the mean ± standard deviation (SD) o f triplicates, unless 
otherwise indicated. The cell viability is calculated as the ratio o f light absorbance o f an 
electroporated cell sample to that o f the negative control cell sample in MTS assay 24 
hours post electroporation.
4.3 Results and Discussions
4.3.1 Structure Characterization by Scanning Electron Microscopy (SEMI 
SEM (AMRAY, 1830) was used to observe the structure o f carbon micro-pillar. 
The PAN nano-fiber samples were coated with 15 nm of metal by a sputter coater 
(CRESSINGTON, 208 HR). SEM images are shown in Figure 4-4.
66
> 8 0 0  3 OkV 8 yntro x 1 Duk S E J i; 5 /23/201 50  Oum
Figure 4-4: SEM images (a) and (b) SU-8 micro-pillar array, (c) and (d) carbon micro­
pillar array, (e) single SU-8 micro-pillar (f) single carbon micro-pillar.
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4.3.2 Carbon Micro-Pillar Array Electroporation 
The same cells, 3T3 cells and K562, were used for both BTX, MAE and plain 
plate systems, adopting a pulse protocol (625 V/cm, single 10 ms pulse) early optimized 
with WizGFP plasmids. For the BTX system with 2-mm gap cuvettes, this is designated 
to a 125 V pulse and for MAE and plain plate, they are 10 V. The two close-placed plain 
electrodes with gold coating surface (no micro-pillar pattern) were also done 
simultaneously for electroporation as a comparison with the carbon plain plate system. 
Successful transfection was observed in all those cases: BTX, gold/carbon-coated plain 
plate electrodes, and gold-coated/carbon micro-pillar electrodes. Figure 4-5 shows 
transfection enhancement o f pGFP plasmids in fluorescence microscopic and phase 
contrast images o f gold coated plain plate, carbon coated plain plate, gold coated MAE 
and carbon coated MAE.
Many cells in each case expressed green fluorescence protein (GFP) 24 hours 
after electroporation (Figure 4-5). More quantitative comparison was done by counting 
the percentage o f GFP-positive cells (Figure 4-6a). Efficiency of pGFP transfection for 
carbon coated and gold coated with closed-placed parallel plain electrodes stayed at the 
same level (~40% for both K562 cells and 3T3 cells), which as expected was generally 
much better than that from BTX (K562: 25.7 ± 1.8%, 3T3: 25.4 ± 3.6%), similar to some 
early micro-scale electroporation observations40, 42. When we focus on the micro-pillar 
array system, the introduction o f carbonization did not show up too much affection on the 
transfection percentage (K562: ~70%, 3T3: ~65%).
Such results confirm the enhancement o f MAE system to the plasmid transfection 
o f mammalian cells. As shown in Figure 4-6, similar transfection performance was found
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for MAE processes using both carbon-based and gold-coated micro-pillar electrodes in 
terms of the transfection efficiency and cell viability. Their enhancement level to the 
commercial system is also about the same. This result offers us some flexibility on the 
choice o f MAE electrode material. Considering the availability o f large-scale 
manufacturing lines (such as hot embossing and microinjection molding facilities), the 
fabrication o f micropillar array using SU-8 or other polymer materials (which can be 
converted into conductive carbon later) could be done quickly without expensive 
fabrication facilities and cleanroom environment. Therefore, the findings here could 
make MAE production largely eliminate the dependence on cleanroom facility and 
become truly competitive in cost with available commercial electroporation setup. In our 
tests below, carbon-based MAE setup was adopted.
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Figure 4-5: Transfection enhancement o f pGFP plasmids in fluorescence microscopic 
and phase contrast images (a) gold coated plain plate; (b) carbon coated plain plate; (c) 
gold coated MAE; (d) carbon coated MAE.
(a)
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Figure 4-6: The effect o f micropillar materials on electroporation performance. The 
transfection efficiency (a) and the cell viability (b) comparison of gold-coated 
electrodes and carbon-based electrodes: for micropillar array electrode (“MAE”), plain 
plate electrode without micropillar pattern (“Plain Plate”), and a commercial system 
(“BTX”). (**) represents p < 0.01, (***) represents p < 0.005, (****) represents p < 
0 .0001 .
4.3.3 Enhancement o f Micro-pillar Array Electroporation on Sima Delivery 
To further demonstrate the effectiveness o f MAE to RNA interference 
applications, we chose small interfering RNA (siRNA) with sequences that could 
specifically silence the expression of GFP and Luciferase. Their knockdown efficiency 
was evaluated by co-transfecting with pGFP or pLuc plasmids. As shown in Figure 4-7a, 
clear suppression of GFP expression is observed when co-delivering pMaxGFP and their 
corresponding siRNA of 5 pmol to K.562 cells in both commercial electroporation system 
(“BTX”) and MAE. More GFP expression is turned off by MAE, with a -53%  further 
drop o f GFP than that in BTX and an overall knockdown level below 30% (Figure 4-7b). 
Similar knockdown enhancement was also observed in A549 cells (Figure 4-7b), 
confirming its broad effectiveness.
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It is worth pointing out that as the co-transfection o f plasmids and siRNA was 
used here, the delivery enhancement on the targeted reporter gene and its corresponding 
siRNA occurred simultaneously in MAE. It must shut off more proteins than the BTX 
system to reach the similar protein expression level. Down regulation o f Luciferase 
plasmid (“pLuc”) was also evaluated by co-transfecting with its corresponding siRNA 
(“GL3”). Compared to the knockdown result from BTX, an additional ~11% drop of 
Luciferase signal was found in MAE when 5 pmol siRNA was used (Figure 4-7c). 
However unlike the knockdown o f pMaxGFP with MAE, a larger dosage (i.e., 30 pmol) 
of siRNA GL3 is needed to shutoff the Luciferase expression level below 30%. Although 
more siRNA probes were introduced into the treated cells by MAE and additional protein 
expression was suppressed, no significant loss o f cell viability was found (Figures 4-7c 
and 4.7d).
(a) pmaxGFP alone pmaxGFP* siRNA
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Figure 4-7: Enhancement on siRNA delivery in 2-pm micropillar MAE. (a) 
Fluorescence images o f K562 cells and (b) fluorescence intensity measurement on GFP 
expression level in K562 and A549 cells when co-transfecting pMaxGFP and its 
corresponding siRNA; (c) the luminescence measurement on Luciferase expression 
level in K562 cells and cell viability when co-transfecting pLuc and knockdown siRNA 
probe (“GL3”); (d) cell viability o f K562 and A549 cells in panel (b). (*) represents p < 
0.05, (**) represents p < 0.01, (***) represents p < 0.005.
4.4 Conclusions
A new synthesis procedure o f conductive material, glass-like carbon, was 
developed and evaluated for its contributions to the delivery efficiency o f DNA with both 
anchor cells and suspension cells. The advantages of this MAE system varied with the 
number, size, and density o f the micropillars while its electroporation performance was 
similar for both gold-coated and carbon-based micropillar electrodes. The series o f test 
results showed identical performance on both glass-like carbon and conventional 
conductive materials. Proleptically, the MAE still showed 2.5-3 folds improvement on 
the transfection efficiency of the plasmid DNA while the cell viability stayed at the same
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level compared with the popular commercial electroporation system. While there was a 
2.5~3 folds improvement on the transfection efficiency o f plasmid DNA, the 
enhancement on the siRNA delivery heavily relied on the probe dosage when co­
transfection strategy was adopted. Thus, well-defined micro-pillar array ensures size 
specific treatment to a large number o f cells regardless of their various sizes, and random 
dispersion states were proven again.
CHAPTER 5
FLOW GUIDED MICRO-PILLAR ARRAY ELECTROPORATION
5.1 Introduction
In recent years, micro-fluidic technology developed rapidly. Different kinds of 
new device designs start to appear. Scientists favor micro-fluidic-based electroporation 
design because o f its unique miniaturization and integration. Its advantage is unique. 
First, through standard microfabrication techniques, such as photolithography, the 
manufacturing o f the micro-fluidic electroporation system becomes easy to achieve. 
Secondly, the various micro-electrodes are incorporated into the device which can 
produce the desired electric field. Reduced distance between the electrodes to tens of 
microns or even created subcellular size. Due to the proximity o f electrodes required, 
voltage can be remarkably reduced to a few volts. Third, since operating space is 
reduced, a single cell can be manipulated on the chip to detect cell heterogeneity.
Miniaturized system also makes them well suited for reducing rare cells involved 
and expensive reagent consumption. Fourth, another advantage o f system miniaturization 
is the material o f choice diversification. It brings immediate benefits, such as transparent 
materials (such as polydimethylsiloxane (PDMS) and the conductive glass) microchip in 
real-time observation during the electroporation process, which is propitious to exploring 
electric mechanism. Finally, the system also has the advantage that small microfluidic 
devices can generate small current. It is conducive to chemical environment stability and
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rapid cooling. In addition, the micro-fluidic electroporation combined with other analysis 
methods such as dielectrophoresis (DEP), electro-osmosis and hybridization to 
implement a total analysis of the analytical system. This is important for applications 
related to the content of intracellular analysis use.
In this chapter, we present novel micro-fluidic electroporation system owing 
much less invasive and more efficient on gene delivery called Flow guided Micro-pillar 
array Electroporation (FME). We loaded cells in a micro-scaled channel. Cells flowed 
continuously between micro-pillar electrode and plain surface electrode. A batch of 
certain frequency low voltage electric pulses was applied to achieve gene delivery. We 
observed a significant improvement o f gene transfection with minimal cell damage.
5.2 Materials and Methods
5.2.1 Cell Culture
NIH/3T3 cells (ATCC, CRL-1658) were routinely grown and maintained in high 
glucose DMEM supplemented with 10% newborn calf serum (NCS), 1 % penicillin and 
streptomycin, 1% L-glutamine and 1% sodium pyruvate. K562 cells (ATCC, CCL-243) 
and A549 (ATCC, CCL-185) were cultured in RPMI 1640 supplemented with 10% NCS, 
100 U/mL penicillin, 100 pg/mL streptomycin, and 100 pg/mL L-glutamine. All cultures 
were maintained at 37°C with 5% C 02 and 100% relative humidity.
5.2.2 Fabrication and Assembly o f Micro fluidic Device
The flow guided micro-pillar array electroporation (FME) device consists o f a 
PDMS gasket with a straight channel in the middle and sandwiched with a piece o f 
micro-pillar structure electrode and a gold or carbon coated plate electrode. The fixed 
composition was embedded in a pair o f polymethylmethacrylate (PMMA) film (Fisher
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Scientific Inc., USA) holder with tubing used for load and collect cells. As shown in 







Figure 5-1: Micro-fluidic device assembling.
In order to remove all contaminants on the surface, the micro-fluidic device was 
exposed under UV light overnight and then cleaned with 70% alcohol successively rinsed 
with phosphate-buffered saline (PBS).
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5.2.3 Electroporation Procedure 
Bulk electroporation was processed according to the procedure described in 
Section 3.2. The micro-pillar structure enhanced micro-fluidic electroporation system 
includes a multi-functional pulse generator (BTX 830), a syringe with a pump and the 
unit device. The multi-functional pulse generator is able to generate square wave pulse. 
The technical specifications o f the multi-functional pulse generator are given in Table 3.
Table 3: Technical specifications o f the multi-functional pulse generator.
Methods BE MME
Voltage (V) 220 10
Pulse duration (ms) 10 10
No. of pulses 1 27
Pulse Frequency (Hz) N/A 1
In this system, target cells was suspended in 100 pi fresh OPTI-MEM I (a serum 
free medium) at a density of 0.5 * 106 cells/ml. Plasmid DNA (pGFP or pLuc) o f 10 pg 
was then added to make the electroporation sample solution. Afterwards, the sample 
solution would be loaded in a syringe and fixed on a syringe pump. By connecting with 
the tubing, the cells would go through the micro-fluidic device and collected in the tubing 
which was fixed at the other end. The syringe pump was set up at 13.5 ml/h. While the 
cells fulfilled the micro-channel, the multi-functional pulse generator started to provide 
twenty-seven electric pulses at a frequency o f 1. This system settlement ensured each 
single cell suffered and only suffered one pulse during the whole flowing process.
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After collecting all the solution, the cells were transferred to a 12-well plate with 
1 ml culture media in each well. As introduced in Chapter 3, the transfection efficiency 
and cell viability were measured at 24 hours after electroporation.
5.2.4 Polymer Based Nano-Fiber Fabrication 
Nano-fiber electrode material was fabricated through electrospinning process. 
Polyacrylonitrile (PAN, average MW 150,000), N, N-dimethylformamide (DMF, 99.8%) 
were purchased from Sigma-Aldrich (St Louis, MO). Typically, a 10 wt% PAN/DMF 
solution was first prepared by dissolving PAN powders in DMF stirring overnight at 
80°C. The suspension was then loaded in a 10 ml plastic syringe fix on a syringe pump at 
a flow rate o f 0.75 ml h-1. The suspension was extruded through a 30 G stainless steel 
needle (from Nordson EFD Corporation). A grounded aluminum pan was placed at a 15 
cm distance from the end o f needle. A directional current electric bias (24 kV) was added 
between the needle end and the aluminum pan collector through Gamma ES- 40P power 
supply (Gamma High Voltage Research, Inc.). Figure 5-2 shows the electrospining 
process.
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Figure 5-2: Schematic diagram o f fiber formation by electrospining process where a 
droplet o f a polymer solution is elongated by a high electrical field. 
(http://nano.mtu.edu/Electrospinning_start.html).
5.2.5 Nano-Fiber Electrode Carbonization Protocol 
Similar with the SU-8 photoresist process, three stages were needed during PAN 
fiber carbonization. Particular parameters were justified as (1) a temperature ramp from 
room temperature to 280°C at 2°C/min, followed by a 360 min dwell at 280°C in an open 
air environment; (2) a temperature ramp from 280 to 700°C at 10°C/min with a one-hour 
dwell at 700°C to complete carbonization under flowing N2 at 2000 mL/min; and (3) 
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Figure 5-3: Three stages o f PAN nano-fiber carbonization protocol.
5.3 Results and Discussions
5.3.1 Comparison o f FME with Bulk Electroporation 
For comparison purpose, plasmid GFP was used as reporter gene. K562 cells 
(ATCC, CCL-243) and A549 cells (ATCC, CCL-185) were used as model cells. 
Conventional bulk electroporation (designated as BTX) and MFE were tested. A 
significant improvement was expected of green fluorescence protein (GFP) expression by 
using the FME method over the conventional bulk electroporation method. 
Simultaneously in the FME system, due to a much lower electric voltage applied, cell 
viability achieved the same level o f the conventional bulk electroporation method.
As expected, it is easily visualized from Figures 5-4 and 5-5 that successful 
transfection was observed in all three cases with many cells expressing green
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fluorescence protein (GFP). However, for (a) and (b) which present the micro-pillar 
structure enhanced micro-fluidic electroporation gained more pGFP plasmids expressed.
It is further proven again by the quantitative difference on GFP-positive.
Figure 5-4: Transfection enhancements o f pGFP plasmids in FME. Fluorescence 
microscopic and phase contrast images of K562 cells after transfection by 2 pm (a) and 
6 pm (b) pillar structure enhanced microfluidic electroporation and conventional bulk 
electroporation (“BTX”) (c).
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Figure 5-5: Transfection enhancements o f pGFP plasmids in MFE. Fluorescence 
microscopic and phase contrast images o f A549 cells after transfection by 2 pm (a) and 
6 pm (b) pillar structure enhanced microfluidic electroporation and conventional bulk 
electroporation (“BTX”) (c).
As shown in Figures 5-6 and 5-7, the transfection efficiency with micro-pillar 
structure enhanced micro-fluidic electroporation (73.68 ± 0.94%, 71.27 ± 1.6% for 2 pm,
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6 nm A549 cells, and 76.18 ± 2.1%, 70.94 ± 1.1 for 2 ym, 6 ym K.562 cells) is generally 
much better than that from BTX (A549: 22.05 ± 0.87%, K562: 24.62 ± 0.67%). 
Meanwhile, the quantitative differences on cell viability shown in Figures 4-4 and 4-5 
indicate that there is no more loss on the MFE system (80.68 ± 0.30%, 81.54 ± 0.30% for 
2 ym, 6 ym A549 cells, and 82.57 ± 0.76%, 83.56 ± 0.15 for 2 ym, 6 ym K562 cells) 
compare with BTX (A549: 78.64 ± 0.20%, K562: 80.35 ± 0.50%). These results confirm 
the enhancement o f FME on plasmid transfection for mammalian cells. This is not 
surprising considering the actual voltage used in the current FME setup (10 V) is still 
beyond the threshold for electrochemical hydrolysis o f water (~1.3 V). Its negative 
impact on cell survival is minimized, not completely avoided.
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Figure 5-6: Quantitative results o f pGFP plasmids transfection efficiency for K562 (a) 
and A549 (b) cells by 2 pm and 6 pm pillar structure enhanced micro-fluidic 















Figure 5-7: Quantitative results o f electroporation cell viability for K.562 (a) and A549 
(b) cells by 2 pm and 6 pm pillar structure enhanced micro-fluidic electroporation and 
conventional bulk electroporation (“BTX”).
5.3.2 Comparison o f MFE with Different Pulse Frequency 
Considering the results from Section 5.3.1, since the FME cell viability performs 
even better than BTX, it provides us much confidence in improving our electroporation 
protocol on the MFE system further. A logical idea is to create more opportunities on 
forming transient pores on cell membrane. A straight shoot is to increase the 
electroporation pulse number. Thus, K562 cells were chosen as the model cells. Most 
parameters are kept as in Section 5.3.1. Pulse frequency varied as 1 Hz, 10 Hz, and 
infinite (which means a DC current was applied); 24 hours fluorescence microscopic and 
phase contrast images are shown in Figure 5-8.
A549 cell viability
BTX 6um  flow  2um  flow
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Figure 5-8: Transfection enhancements o f pGFP plasmids in FME. Fluorescence 
microscopic and phase contrast images of K562 cells 24 hours after electroporation by 
2 pm pillar structure enhanced micro-fluidic electroporation for pulse frequency 1 Hz, 
10 Hz, and infinite (a, b and c).
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Successful transfection was observed in all three cases with many cells expressing 
green fluorescence protein (GFP). All these cases present a high level on transfection 
efficiency.
Figure 5-9 provides the particular data. The transfection efficiency (76.18 ± 2.1% 
for 1 Hz, 84.30 ± 3.07% for 10 Hz, and 89.40 ± 2.57% for infinite) was generally kept in 
the same range of 75% to 90%. However, when we look at cell viability, it is a different 
story. For 1 Hz and 10 Hz the viabilities are, respectively, 82.57 ± 0.95% and 78.18 ± 
5.05%, which can be considered indiscriminate. There is approximately a 30% drop on 
infinite pulse frequency (51.99 ± 3.67%). The significant difference brings us to ascribe 
the harm came from a continual current.




K562 cell viability on various pulse 
frequency
Infinite
Figure 5-9: K562 cell transfection efficiency and cell viability on various pulse 
frequencies.
5.3.1 Comparison of MFE with Different Pulse Frequency 
Using the same material and set up with carbon micro-pillar based 
electroporation, a comparison made between plain plate, carbon micro-pillar and carbon 
nano-fiber based electroporation. Figure 5-10 shows transfection enhancement o f pGFP 
plasmids in fluorescence microscopic and phase contrast images o f carbon nano-fiber 
based electroporation.
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Figure 5-10: Transfection enhancement o f pGFP plasmids in fluorescence microscopic 
and phase contrast images of carbon nano-fiber based electroporation.
In all cases, green fluorescence protein (GFP) were expressed 24 hours after 
electroporation (Figure 5-10). More quantitative comparisons were done by counting the 
percentage o f GFP-positive cells (Figure 5-1 la). Efficiency o f pGFP transfection for 
plain plate carbon fiber and carbon pillar increased the gradatim (-40%  for plain plate, 
-55%  for carbon fiber and -70  for carbon pillar), which was genenally expected to be 
much better than that from BTX (K562: 25.7 ± 1.8%, 3T3: 25.4 ± 3.6%). For the cell 
viability, all of them showed great bio-stability.
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Figure 5-11: Presents the pGFP transfection efficiency (a) and cell viability (b) 
difference between plain plate, fiber-based and pillar-based electroporation.
5.4 Conclusions
A new micro-pillar structure enhanced by the micro-fluidic electroporation (FME) 
system approach was demonstrated using plasmids GFP as model materials. K562 cells 
(ATCC, CCL-243) and A549 cells (ATCC, CCL-185) were tested, and a significant
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improvement in transgene expression was observed compared to current electroporation 
techniques. In the MFE method, the focused electric field enhances cell permeabilization 
at a low electric voltage, leading to high cell viability; more important, the micro-pillar 
configuration is able to provide better electric field distribution near the cell surface, 
facilitating gene delivery into the cells.
Successful examples o f in vitro electroporation trials have been done on animal 
and human patients. Since typically cells or tissues from the patients are very limited and 
therapeutic materials such as plasmids and oligonucleotides are very expensive, our FME 
method with the ability to deal with a small number o f cells with high transfection 
efficiency and cell viability offers a great impossibility for ex vivo gene therapy. The 
applicability o f the MSE method to primary cells and hard-to-transfect cells (such as 




A new micro-pillar array electroporation (MAE) approach was developed and 
demonstrated using plasmids GFP and gWiz Luciferase as reporter genes. Several cell 
lines, such as NIH 3T3 fibroblasts, K562 cells (ATCC, CCL-243) and A549 (ATCC, 
CCL-185) cells, were tested and a significant improvement in transgene expression and 
cell viability was observed compared to current electroporation techniques. In the MAE 
method, the focused electric field enhances cell permeabilization at a lower electric 
voltage, leading to high cell viability. Furthermore, the micro scaled pulse applied space 
is able to provide better gene confinement near the cell’s surface, facilitating gene 
delivery into the cells.
We also demonstrated the use o f polymer pyrolysis technic to fabricate low cost, 
multiple reutilized conductive carbon electrodes. By applying carbon material on our 
MAE system, we observed the same high gene transfection and excellent cell viability as 
the gold coated electrodes compared to that achieved with the bulk electroporation 
methods. The good performance on carbon electrodes provides new choices on the 
electrodes material for biological environment.
For large volume production, a flow guided MAE electroporation system was 
successfully integrated. Using plasmids GFP and gWiz Luciferase as reporter genes, 
K562 cells (ATCC, CCL-243) and A549 (ATCC, CCL-185) cells were tested for
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electroporation. Significant improvement o f gene delivery efficiency with equal or even 
better cell survival and recover rates were observed compared to conventional 
electroporation methods. Due to its ability to continuously work with assortative flowing 
rate and electric pulse frequency, the flow guided MAE system has the potential for 
large-scale industrial production.
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